This is a contrast between CytRx Corporation (NASDAQ:CYTR) and Intec Pharma Ltd. (NASDAQ:NTEC) based on their risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation. The two companies are Biotechnology and they also compete with each other.
Table 1 shows gross revenue, earnings per share and valuation of the two companies.
Table 2 has CytRx Corporation and Intec Pharma Ltd.’s return on assets, net margins and return on equity.
Institutional Insider Ownership
The shares of both CytRx Corporation and Intec Pharma Ltd. are owned by institutional investors at 10.2% and 39.64% respectively. CytRx Corporation’s share held by insiders are 8.5%. Comparatively, 11.81% are Intec Pharma Ltd.’s share held by insiders.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past year CytRx Corporation was more